2 ms·
The cell therapies are really expensive and struggling with manufacturing costs, mabs like these are priced what they are because of market forces.
by vikramkr 3y ago
The cell therapies are really expensive and struggling with manufacturing costs, mabs like these are priced what they are because of market forces.